These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, Bittar R, Seilhean D, Hauw JJ, Lacomblez L, Loeffler JP, Meininger V. Neurology; 2008 Mar 25; 70(13):1004-9. PubMed ID: 18199832 [Abstract] [Full Text] [Related]
23. [Longitudinal analysis of age at onset and initial symptoms in patients with amyotrophic lateral sclerosis]. Shimohata T, Yanagawa K, Tanaka K, Nishizawa M. Rinsho Shinkeigaku; 2006 Jun 25; 46(6):377-80. PubMed ID: 16986697 [Abstract] [Full Text] [Related]
25. The natural history of central motor abnormalities in amyotrophic lateral sclerosis. Mills KR. Brain; 2003 Nov 25; 126(Pt 11):2558-66. PubMed ID: 12937082 [Abstract] [Full Text] [Related]
30. [Neurological and neuropathological studies of amyotrophic lateral sclerosis/parkinsonism-dementia complex in the Kii Peninsula of Japan]. Kokubo Y, Kuzuhara S. Rinsho Shinkeigaku; 2001 Nov 25; 41(11):769-74. PubMed ID: 12080607 [Abstract] [Full Text] [Related]
31. Atypical parkinsonism of Japan: amyotrophic lateral sclerosis-parkinsonism-dementia complex of the Kii peninsula of Japan (Muro disease): an update. Kuzuhara S, Kokubo Y. Mov Disord; 2005 Aug 25; 20 Suppl 12():S108-13. PubMed ID: 16092099 [Abstract] [Full Text] [Related]
32. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database. Miller RG, Anderson F, Brooks BR, Mitsumoto H, Bradley WG, Ringel SP, ALS CARE Study Group. Ann Neurol; 2009 Jan 25; 65 Suppl 1():S24-8. PubMed ID: 19191307 [Abstract] [Full Text] [Related]
33. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study. Vázquez MC, Ketzoián C, Legnani C, Rega I, Sánchez N, Perna A, Penela M, Aguirrezábal X, Druet-Cabanac M, Medici M. Neuroepidemiology; 2008 Jan 25; 30(2):105-11. PubMed ID: 18334826 [Abstract] [Full Text] [Related]
34. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version]. Ohashi Y, Tashiro K, Itoyama Y, Nakano I, Sobue G, Nakamura S, Sumino S, Yanagisawa N. No To Shinkei; 2001 Apr 25; 53(4):346-55. PubMed ID: 11360474 [Abstract] [Full Text] [Related]
35. The pseudopolyneuritic form of amyotrophic lateral sclerosis (Patrikios' disease). Cappellari A, Ciammola A, Silani V. Electromyogr Clin Neurophysiol; 2008 Mar 25; 48(2):75-81. PubMed ID: 18435211 [Abstract] [Full Text] [Related]
36. Amyotrophic lateral sclerosis (Lou Gehrig's disease) is caused by electric currents applied to or induced in the body: it is an iatrogenic disease of athletes caused by use of electrotherapy devices. Milham S. Med Hypotheses; 2010 Jun 25; 74(6):1086-7. PubMed ID: 20189317 [No Abstract] [Full Text] [Related]
40. Hopkins researchers close in on cause of Lou Gehrig's disease. Compr Ther; 1992 Jun 25; 18(6):15. PubMed ID: 1511589 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]